AS A PART OF OCTANT'S LSD TEAM, YOU'LL: Design, develop, and validate cell-based assays that characterize small-molecule correctors for Fabry disease and an additional target and verify their target pharmacology, using plate-reader, high-content imaging, and flow cytometry readouts. Although the day-to-day work is centered on mammalian cells, what matters most to us is a strong track record of designing mechanistic assays, and we welcome candidates trained in molecular biology, cell biology, chemical biology, biochemistry, or related fields.